Contract 75A50325F80037
Sagent Pharmaceuticals, Inc · Department Of Health And Human Services · September 26, 2025
Sagent Pharmaceuticals, Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2025 for $16.64 million of work in pharmaceutical preparation manufacturing. Performance is in Hines, IL. This is a task or delivery order issued under parent IDIQ 36F79724D0107. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75A50325F80037
- Parent IDIQ
- 36F79724D0107
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Hines, IL
- First action
- September 26, 2025
Description
CIPROFLOXACIN SOLUTION FOR INJECTION, 400MG/ 200ML FLEXI-BAG
Modification timeline
-
September 26, 2025Base award$16.64M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325F80037?
Contract 75A50325F80037 is a federal contract awarded to Sagent Pharmaceuticals, Inc by Department Of Health And Human Services on September 26, 2025 for $16.64 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50325F80037?
Sagent Pharmaceuticals, Inc won contract 75A50325F80037 from Department Of Health And Human Services.
How much is contract 75A50325F80037 worth?
Contract 75A50325F80037 has obligated $16.64 million to date.